|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00911365 |
|
Date of registration:
|
26/05/2009 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy
|
|
Scientific title:
|
A Double-blind Placebo-controlled Randomized Clinical Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy |
|
Date of first enrolment:
|
May 2008 |
|
Target sample size:
|
27 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00911365 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
|
|
Phase:
|
Phase 2
|
|
|
Countries of recruitment
|
|
Korea, Republic of
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- 75 Years Old or Less
- Multiple System Atrophy
- Voluntary Participants
Exclusion Criteria:
- Doubted dementia (MMSE < 24)
- Severe febrile condition
- Serum SGOT/SGPT three times above
- Malignant mass
Age minimum:
N/A
Age maximum:
75 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Multiple System Atrophy
|
|
Intervention(s)
|
|
Biological: normal saline
|
|
Biological: autologous mesenchymal stem cells
|
|
Primary Outcome(s)
|
|
Scores on unified MSA rating scale
[Time Frame: one month]
|
|
Secondary ID(s)
|
|
4-2008-0137
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|